Pharma Journalist, Author at Pharma Journalist - Page 47 of 784

Bayer and Broad Institute extend cancer therapy research collaboration

Felzartamab Granted Breakthrough Therapy Designation by U.S. Food and Drug Administration (FDA) for Primary Membranous Nephropathy (PMN)

Sosei Heptares Will Receive US$3.75 Million Payment in Multi-Target Partnership

FDA approves Novartis Cosentyx as the first new biologic treatment option for hidradenitis suppurativa patients in nearly a decade

GSK enters agreement to obtain exclusive license for JNJ-3989 to expand the development of bepirovirsen

Kite and Epic Bio Announce Collaboration to Develop New Therapies for Cancer

Vect-Horus Enters Exclusive License Agreement with Novo Nordisk to Develop Targeted Therapeutics

Day One Announces FDA Acceptance of NDA and Priority Review for Tovorafenib in Relapsed or Progressive Pediatric Low-Grade Glioma (pLGG)

FDA Approves Genentech’s Vabysmo for the Treatment of Retinal Vein Occlusion (RVO)

FDA Accepts ImmunityBio’s BLA Resubmission as Complete and Sets New PDUFA Date